QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

NPCE

QT55NeuroPace, Inc.
NASDAQ·Healthcare·Medical - Devices·USA
Latest market price
15.63
+0.47+3.10%
OverviewShort InterestFilings
NPCEQT55NeuroPace, Inc.·NASDAQ
OverviewShort InterestFilings
15.63+3.10%
TA
Loading chart...
Screen all →
ABT-0.10%$88.41ISRG+1.14%$406.78SYK+2.21%$307.80MDT+1.54%$79.34BSX+0.76%$45.29EW+0.78%$87.36DXCM+1.74%$72.47RMD+1.26%$188.63
Snapshot
Index-P/E-EPS (ttm)-
Insider Own-
Shs Outstand34.09M
Perf Week-1.33%
Market Cap516.86MForward P/E-EPS next Y-0.33Insider Trans0.00%Shs Float-Perf Month-1.39%
Enterprise Value572.54MPEG-EPS next Q-0.19Inst Own-Short Float-Perf Quarter19.04%
Income-21811542.00P/S5.19EPS this Y-Inst Trans-Short Ratio-Perf Half Y-1.57%
Sales99.53MP/B35.36EPS next Y45.66%ROA-21.81%Short Interest-Perf YTD1.23%
Book/sh-P/C-EPS next 5Y-ROE-120.74%52W High19.60 -20.26%Perf Year44.99%
Cash/sh-P/FCF-EPS past 3/5Y-ROIC-19.74%52W Low7.56 106.75%Perf 3Y-
Dividend Est.-EV/EBITDA-41.37Sales past 3/5Y-Gross Margin78.29%Volatility2.97% 3.37%Perf 5Y-
Dividend TTM-EV/Sales5.75EPS Y/Y TTM-Oper. Margin-16.84%ATR (14)0.80Perf 10Y-
Dividend Ex-Date-Quick Ratio4.35Sales Y/Y TTM-Profit Margin-21.67%RSI (14)46.64Recom2.10
Dividend Gr. 3/5Y-Current Ratio5.38EPS Q/Q38.10%SMA20-2.79%Beta1.44Target Price20.00
Payout0.00%Debt/Eq4.87Sales Q/Q-SMA50-3.80%Rel Volume0.96Prev Close15.16
Employees184LT Debt/Eq-EarningsAug 11SMA2009.48%Avg Volume175.55KPrice15.63
IPO DateApr 22, 2021Option/ShortYes / YesEPS/Sales Surpr.31.58% 0.00%Net Debt/EBITDA-4.02Volume168,456Change3.10%
Analyst Ratings
DateActionAnalystRatingTarget
May-15-26ReiteratedH.C. Wainwright$19 → $20
Jan-27-26ReiteratedH.C. Wainwright$18 → $19
Dec-16-25ReiteratedUBSBuy$18 → $22
Dec-09-25ReiteratedUBS$18
Nov-05-25ReiteratedLeerink Partners$19
Nov-05-25ReiteratedCantor FitzgeraldOverweight$11 → $16
Aug-14-24ReiteratedWells FargoOverweight$20 → $15
May-23-24ReiteratedLake StreetBuy$20
Mar-14-24UpgradeWells FargoEqual Weight → Overweight$20
Nov-10-23ReiteratedCantor Fitzgerald$11
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Insider Trading Volume
$17.16$15.77$14.38$12.98$11.59● Close Price0.00K99.81K199.63K299.44K399.25KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Morrell MarthaCHIEF MEDICAL OFFICERDec 15 '25Sale15.9725,000399,25049,964Mar 04 12:00 AM
ORBIMED ADVISORS LLC10% OwnerMay 14 '25Sale15.85168,1362,665,3333,238,199May 16 12:00 AM
Morrell MarthaCHIEF MEDICAL OFFICERFeb 21 '25Sale13.7278,3341,074,84481,993Feb 25 12:00 AM
Morrell MarthaCHIEF MEDICAL OFFICERFeb 12 '24Option Exercise0.03100,0002,600160,327Feb 25 12:00 AM
Morrell MarthaCHIEF MEDICAL OFFICERJan 31 '24Option Exercise0.03105,4282,741180,449Feb 25 12:00 AM
KCK LTD.10% OwnerFeb 20 '25Sale9.405,270,84549,545,9430Feb 20 12:00 AM
Morrell MarthaCHIEF MEDICAL OFFICERJan 30 '25Sale15.002003,00086,762Jan 31 12:00 AM
Morrell MarthaCHIEF MEDICAL OFFICERJan 29 '25Sale15.001001,50086,962Jan 31 12:00 AM
Morrell MarthaCHIEF MEDICAL OFFICERJan 24 '25Sale15.013,20048,03287,062Jan 28 12:00 AM
KCK LTD.10% OwnerOct 25 '24Sale5.45223,9911,221,0425,270,845Oct 28 12:00 AM
KCK LTD.10% OwnerOct 23 '24Sale6.021478855,494,836Oct 28 12:00 AM
KCK LTD.10% OwnerOct 22 '24Sale6.094,08224,8535,494,983Oct 24 12:00 AM
KCK LTD.10% OwnerOct 21 '24Sale6.103,72022,6795,499,065Oct 22 12:00 AM
KCK LTD.10% OwnerOct 18 '24Sale6.294,87830,6925,502,785Oct 22 12:00 AM
KCK LTD.10% OwnerOct 17 '24Sale6.283,29420,6865,507,663Oct 18 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR